Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tripat Kaur Ltd is a professional medical consultancy and private practice entity led by Dr. Tripat Kaur, a distinguished executive in the biopharmaceutical industry. The company provides strategic advisory services focusing on clinical development, medical affairs, and global health strategy, particularly in the fields of infectious diseases and mRNA therapeutics. Dr. Kaur has held high-level positions at major firms such as ViiV Healthcare, GSK, and CureVac, and this entity facilitates her expert contributions to the life sciences sector. The firm is registered in the United Kingdom and operates within the broader healthcare and biotechnology ecosystem. Her leadership has been instrumental in advancing treatments for HIV and developing innovative vaccine platforms. The consultancy serves as a bridge between clinical medicine and large-scale pharmaceutical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr Tripat Kaur.